Skip to main content

Table 1 Patient characteristics and scan results

From: 68Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle

Patient Number Age (years) Treatment PSA (ng/mL) 11C-Choline 68Ga-PSMA MR (pelvic)
1 67 RT/HT 8.7 Positive Positive Positive
2 61 RT/HT 10 Positive Positive Positive
3 55 RT/HT 93.85 Positive Positive Negative
4 60 Surgery 0.98 Negative Positive Negative
5 68 RT/HT 2.33 Positive* Positive Positive
6 76 Surgery 0.32 Positive Positive Positive
7 58 Surgery 1.32 Negative Negative Negative
8 58 Surgery 4.44 Positive Positive Positive
9 50 Surgery/RT/QT/HT 3.54 Positive Positive Positive
10 63 Surgery 1.7 Positive Positive Negative
11 76 RT/HT 138 Positive* Positive Positive
12 77 Surgery/HT 6 Positive Positive Positive
13 72 Surgery 0.55 Negative Negative Negative
14 64 RT/HT 4.33 Equivocal Positive Positive
15 71 Surgery/RT/QT/HT 6.5 Positive Positive Negative
16 67 Surgery/RT 3,5 Negative Positive Negative
17 55 RT 11 Positive Positive Positive
18 62 RT/HT 0.4 Positive Positive Positive
19 56 Surgery 0.88 Negative Negative Negative
20 66 Surgery 1.32 Negative Negative Negative
21 63 Surgery 0.3 Negative Negative Negative
22 65 Surgery/RT 1.29 Negative Positive Negative
23 63 RT 3.96 Positive Positive Positive
24 74 RT 7 Positive Positive Positive
25 73 Surgery/RT/HT 4.79 Positive Positive Positive
26 74 Surgery/RT 0.328 Negative Negative Negative
27 69 Surgery/RT/HT 5.8 Equivocal Positive* Positive
28 63 RT/HT 2.87 Positive Equivocal Positive
29 62 Surgery/HT 2.56 Negative Positive Negative
30 72 RT 1.76 Equivocal Positive Positive
31 60 Surgery 8.4 Equivocal Positive Positive
32 70 Surgery/RT 19 Positive Positive Negative
33 45 Surgery 0.2 Negative Negative Negative
34 60 Surgery/RT/HT 15 Positive Positive Positive
35 72 Surgery 3.16 Equivocal Positive Positive
36 63 Surgery 0.2 Equivocal Equivocal Positive
  1. RT = Radiation Therapy; HT = Hormonal Therapy; QT = Chemo therapy; MR = Magnetic Resonance; “Positive*” = means “positive” at lymph nodes or bone lesions and “equivocal” at prostate bed